Q4 2022 Sangamo Therapeutics Inc Earnings Call Transcript
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Sangamo Fourth Quarter 2022 Earnings Conference Call. (Operator Instructions)
At this time, I would like to turn the conference over to Ms. Louise Wilkie. Ma'am, please begin.
Thank you. Good afternoon. I'm Louise Wilkie, Sangamo's Vice President of Investor Relations and Corporate Communications. Thank you for joining us on the call today.
On this call are several members of the Sangamo executive leadership team, including Sandy Macrae, Chief Executive Officer; Mark McClung, Chief Operating Officer; Prathyusha Duraibabu, Chief Financial Officer; Jason Fontenot, Chief Scientific Officer; Nathalie Dubois-Stringfellow, Chief Development Officer; Bettina Cockroft, Chief Medical Officer; and Andy Ramelmeier, Head of Technical Operations.
Slides from our corporate presentation can be found at our website, sangamo.com, under the Investors & Media section on the Events and Presentations page. This call includes forward-looking statements regarding
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |